tradingkey.logo
搜尋

Avalon Globocare Corp

ALBT
添加自選
0.341USD
-0.006-1.79%
收盤 05/15, 16:00美東報價延遲15分鐘
1.65M總市值
虧損本益比TTM

Avalon Globocare Corp

0.341
-0.006-1.79%
查看詳細走勢圖
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.79%

5天

-14.80%

1月

-17.88%

6月

-81.17%

今年開始到現在

-71.60%

1年

-90.84%

TradingKey Avalon Globocare Corp股票評分

單位: USD 更新時間: 2026-05-15

操作建議

Avalon Globocare Corp當前公司基本面數據相對謹慎,最新ESG揭露屬於行業中等水平。增長潛力較大。當前估值合理,在醫療設備與耗材行業排名159/206位。機構持股佔比非常高,中期看,股價處於下降通道。近一個月,市場表現非常差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Avalon Globocare Corp評分

相關信息

行業排名
159 / 206
全市場排名
477 / 4482
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Avalon Globocare Corp亮點

亮點風險
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
估值高估
公司最新PE估值-0.06,處於3年歷史高位
機構減倉
最新機構持股83.03K股,環比減少34.57%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉0.00股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.75

分析師目標

基於 0 分析師
--
評級
--
目標均價
--
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Avalon Globocare Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Avalon Globocare Corp簡介

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
公司代碼ALBT
公司Avalon Globocare Corp
CEOJin (David)
網址https://www.avalon-globocare.com/
KeyAI